Paid episode

The full episode is only available to paid subscribers of Harnessing the Power of Nutrients

219: Can sulforaphane hurt the thyroid?

Masterjohn Q&A Files Episode 219


Question: Can sulforaphane hurt the thyroid?

What I can say is that sulforaphane does generate thiocyanate ions, which do inhibit uptake of iodine into the thyroid and mammary glands. Although that is a matter of the ratio between isothiocyanate, or between thiocyanate ions and iodine. And so in principle, most uses of sulforaphane, in the context of adequate iodine shouldn't be an issue. I believe at some dose you're going to run into a problem with balancing with iodine, especially in people who have marginal iodine status, but I don't have any studies to back up what point that is. But I have seen cases of people where they got brain fog when they were taking sulforaphane and it went away when they took iodine.

This Q&A can also be found as part of a much longer episode, here:

082: Ask Me Anything About Nutrition, February 7, 2021

From now through March, I will be working full-time on finishing my Vitamins and Minerals 101 book, while reserving a portion of my time for consulting clients. You can pre-order my book at You can sign up for a consultation at

DISCLAIMER: I have a PhD in Nutritional Sciences and my expertise is in performing and evaluating nutritional research. I am not a medical doctor and nothing herein is medical advice.

Listen to the Audio

I highly recommend watching the video above but you can also listen to the audio here:

Read the Transcript or Leave a Comment

Masterpass members have access to the transcript below.

Masterpass members can also read and leave comments below. Non-members can read and leave comments on the general podcast page.

Learn more about the Masterpass here.

The Masterjohn Q&A Files
We use Zoom, a video chatting software, in webinar mode. You can ask your question anonymously in text, but you can also ask it publicly, and you can even get "on stage" and share your mic, web cam, or screen with everyone.
Chris Masterjohn, PhD